UNSPSC 51372310: Pheneridine

This classification denotes an opioid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2UG271VI0Z. European Medicines Agency schedules Pheneridine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09758MIG. Pheneridine generally arises in the molecular formula C22H27NO2. The term PHENERIDINE is an International Non-Proprietary Name or INN. PHENERIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule pheneridine under HS 29333999 and SITC 51574. As of Q4 2014, PHENERIDINE remains the US FDA Preferred Term for this commodity. Pheneridine bears US NLM identifiers UMLS ID C1882364 and NCI Concept Code C66370. SMILES: O(C(=O)C1(CCN(CC1)CCC1CCCCC1)C1CCCCC1)CC.

UNSPSC 51372310 Pheneridine is a Commodity code that in recent state and local procurement activity encompasses naloxone, safe drug deactivation systems, generic multi-source pharmaceuticals, and over-the-counter products procured by health agencies, county governments, and state purchasing cooperatives to support community health, pharmacy benefit programs, and emergency response initiatives. Issuing bodies include county health departments, state health and human services commissions, and multistate cooperative purchasing alliances. The scope of work spans annual bulk procurement of life-safety pharmaceuticals with quarterly delivery schedules, direct-to-manufacturer prescription program development and vendor qualification, and cooperative purchasing agreements for generic drugs distributed through authorized wholesalers to multiple state and local government facilities across member jurisdictions.

Seminole County, Florida; the Texas Health and Human Services Commission; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) represent recent activity. The Seminole County procurement, issued as IFB 60459723LAS with a response deadline of July 26, 2023, seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to Seminole County Community Health Building in Sanford, Florida. MMCAP, administered by the Minnesota Department of Administration, issued RFP S1070000015802 due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota, Oregon, and other member jurisdictions, with awarded vendors effective July 1, 2026. The Texas HHS Commission issued RFI HHS0017013, posted April 3, 2026, to gather vendor information on direct-to-manufacturer prescription capabilities and market intelligence for a Therapeutic Pharmacy Initiative. Recent activity centers in Florida, Texas, and the Upper Midwest cooperative region.